InterventionsReview
SAT-662 GLP-1 And Advanced NASH: Impact On Liver Fibrosis Regression
ENDO 2025 Abstract
The paper
Bocato AC, Baasch LH, Pin VL et al.
ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND
Presented at ENDO 2025
Related
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026